Communications Chemistry, Published online: 29 September 2026; doi:10.1038/s42004-026-02222-0Understanding and manipulating protein–protein interactions (PPIs) with spatiotemporal precision is crucial for advancing protein function studies. Here, the authors summarise recent advances in traceless ligand-directed labelling (t-LDL), a promising strategy that enables selective, minimally invasive tagging of proteins in native cellular contexts.

Blood cholesterol level chart showing normal, borderline, and high risk ranges for total cholesterol, triglycerides, LDL, and HDL, plus how often to test.

YouTube video by コレステロール改善生活【ゆっくり解説】

Comparing biomarker profiles measured at similar ages, but earlier in life, among exceptionally long-lived individuals and their shorter-lived peers can improve our understanding of aging processes. T...

This TimeCapsule reviews the major transformations in lipid metabolism and cardiovascular disease prevention during the first quarter of the 21st century and their impact on clinical practice. From la...

YouTube video by The Lancet

This article reconstructs the development of Jean-Pol Martin’s work from late-1960s concerns withparticipation to Learning by Teaching (LdL), anthropological needs, networked knowledgeconstruction, th...

US LDL Test Market to Grow at a CAGR of 6.879% (2025 - 2035), US LDL Test Market Industry Analysis by Type, Components, Application, End Users

Su elevada proporción de grasas saturadas puede aumentar el colesterol LDL; especialistas y guías cardiovasculares aconsejan priorizar aceites vegetales ricos en grasas insaturadas Redacción: Redacción Mundo de la SaludEditor: Karem Díaz S. El aceite de coco ha adquirido durante los últimos años una reputación de alimento saludable y aparece con frecuencia en recetas, productos procesados […]

Doença genética rara e grave provoca níveis muito elevados de colesterol LDL desde o nascimento

La iniciativa 'Tu línea roja 55' busca concienciar sobre la importancia de mantener el colesterol malo bajo

19.09.2026 - Damar sağlığını bozan en büyük faktör LDL (kötü kolesterol) yeterince önemsenmiyor.

O controle inicial do LDL não é suficiente; e discussão acerca da terapia antitrombótica após OAAE

A groundbreaking Phase 1 clinical trial conducted by Cleveland Clinic has revealed that a single infusion of a CRISPR-Cas9 gene-editing therapy significantly reduced levels of "bad" cholesterol (LDL)

Las nuevas guías europeas de 2025 cambian el criterio tradicional y ya no esperan a los 50 años para empezar a vigilar el colesterol.

In a small first-in-human trial, a single CRISPR-Cas9 infusion that switches off the ANGPTL3 gene in the liver kept LDL cholesterol 53% lower and triglycerides 48% lower after one year, with no treatm

A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion ...